Peripheral blood microvesicles are potential biomarkers for hepatocellular carcinoma

Cancer Biomarkers

Volumn 13, Issue 5, 2013, Pages 351-357

  Wang, Wenjie ^a,b   Li, Huiyu ^a   Zhou, Yan ^a   Jie, Shenghua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

AFP; Diagnosis; HCC; MVs

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER SIZE; CANCER STAGING; CENTRIFUGATION; CHEMOEMBOLIZATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRINKING BEHAVIOR; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HUMAN; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; MICROVASCULATURE; MIDDLE AGED; PERIPHERAL BLOOD MICROVESICLE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING HABIT; THROMBOCYTE COUNT;

AFP; DIAGNOSIS; HCC; MVS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; EARLY DETECTION OF CANCER; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ROC CURVE; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84892940392     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130370     Document Type: Article

References (35)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman, Global cancer statistics, CA Cancer J. Clin., 61(2011) 69-90
2. B. Rampone, B. Schiavone, A. Martino, C. Viviano, and G. Confuorto,Current management strategy of hepatocellular carcinoma, World J. Gastroenterol., 15 (2009) 3210-3216
3. B.H. Zhang, B.H. Yang, and Z.Y. Tang, Randomized controlled trial of screening for hepatocellular carcinoma, J. Cancer Res. Clin. Oncol., 130 (2004) 417-422
4. J. Bruix, and M. Sherman, Management of hepatocellular carcinoma. an update, Hepatology, 53 (2011) 1020-1022
5. A.S. Lok, R.K. Sterling, J.E. Everhart, E.C. Wright, J.C. Hoefs, A.M. Di Bisceglie, T.R.Morgan, H.Y. Kim,W.M. Lee, H.L. Bonkovsky, and J.L. Dienstag, Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma, Gastroenterology, 138(2010) 493-502
6. K. Soga, T.Watanabe, K. Aikawa, M. Toshima, K. Shibasaki, and Y. Aoyagi, Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma. clinical significance in small hepatocellular carcinoma, Hepatogastroenterology, 45 (1998) 1737-1741
7. R.Masuzaki, S.J.Karp, andM. Omata, New serum markers of hepatocellular carcinoma, Semin. Oncol., 39 (2012) 434-439
8. G. Bertino, A. Ardiri, M. Malaguarnera, G. Malaguarnera, N. Bertino, and G.S. Calvagno, Hepatocellualar carcinoma serum markers, Semin. Oncol., 39 (2012) 410-433
9. E. Cocucci, G. Racchetti, and J. Meldolesi, Shedding microvesicles. artefacts no more, Trends Cell Biol., 19 (2009)43-51
10. A. Ginestra, M.D. La Placa, F. Saladino, D. Cassara, H. Nagase, and M.L. Vittorelli, The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness, Anticancer Res., 18 (1998) 3433-3437
11. V. Muralidharan-Chari, J.W. Clancy, A. Sedgwick, and C. D'Souza-Schorey, Microvesicles. mediators of extracellular communication during cancer progression, J. Cell Sci., 123(2010) 1603-1611
12. J.S. Schorey and S. Bhatnagar, Exosome function. from tumor immunology to pathogen biology, Traffic., 9 (2008) 871-881
13. J. Ratajczak, M. Wysoczynski, F. Hayek, A. Janowska-Wieczorek, and M.Z. Ratajczak, Membrane-derived microvesicles. important and underappreciated mediators of cell-to-cell communication, Leukemia, 20 (2006) 1487-1495
14. J. Rak, Microparticles in cancer, Semin. Thromb. Hemost., 36(2010) 888-906
15. A. Aharon and B. Brenner, Microparticles, thrombosis and cancer, Best. Pract. Res. Clin. Haematol., 22 (2009) 61-69
16. F.F. van Doormaal, A. Kleinjan, M. Di Nisio, H.R. Buller, and R. Nieuwland, Cell-derived microvesicles and cancer, Neth. J. Med., 67 (2009) 266-273
17. J.M. Inal, E.A. Ansa-Addo, D. Stratton, S. Kholia, S.S. Antwi-Baffour, S. Jorfi, and S. Lange, Microvesicles in health and disease, Arch. Immunol. Ther. Exp. (Warsz.), 60 (2012)107-121
18. D.G. Tang, and C.J. Conti, Endothelial cell development, vasculogenesis, angiogenesis, and tumor neovascularization. an update, Semin. Thromb. Hemost., 30 (2004) 109-117
19. I. Giusti, S. D'Ascenzo, and V. Dolo, Microvesicles as potential ovarian cancer biomarkers, Biomed. Res. Int., 2013(2013) 703048
20. T.E. Ichim, Z. Zhong, S. Kaushal, X. Zheng, X. Ren, X. Hao, J.A. Joyce, H.H. Hanley, N.H. Riordan, J. Koropatnick, V. Bogin, B.R.Minev,W.P.Min, and R.H. Tullis, Exosomes as a tumor immune escape mechanism. possible therapeutic implications, J. Transl. Med., 6 (2008) 37
21. V. Huber, S. Fais, M. Iero, L. Lugini, P. Canese, P. Squarcina, A. Zaccheddu, M. Colone, G. Arancia, M. Gentile, E. Seregni, R. Valenti, G. Ballabio, F. Belli, E. Leo, G. Parmiani, and L. Rivoltini, Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles. role in immune escape, Gastroenterology, 128 (2005) 1796-1804
22. G. Andreola, L. Rivoltini, C. Castelli, V. Huber, P. Perego, P. Deho, P. Squarcina, P. Accornero, F. Lozupone, L. Lugini, A. Stringaro, A. Molinari, G. Arancia, M. Gentile, G. Parmiani, and S. Fais, Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles, J. Exp. Med., 195(2002) 1303-1316
23. C. Friend, W. Marovitz, G. Henie, W. Henie, D. Tsuei, K. Hirschhorn, J.G. Holland, and J. Cuttner, Observations on cell lines derived from a patient with Hodgkin's disease, Cancer Res., 38 (1978) 2581-2591
24. H.A. Edmondson, and P.E. Steiner, Primary carcinoma of the liver. a study of 100 cases among 48,900 necropsies, Cancer, 7 (1954) 462-503
25. A. Mrvar-Brecko, V. Sustar, V. Jansa, R. Stukelj, R. Jansa, E. Mujagic, P. Kruljc, A. Iglic, H. Hagerstrand, and V. Kralj-Iglic, Isolated microvesicles from peripheral blood and body fluids as observed by scanning electron microscope, Blood Cells Mol. Dis., 44 (2010) 307-312
26. V. Dolo, E. Adobati, S. Canevari, M.A. Picone, and M.L. Vittorelli, Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-Associated surface antigens, Clin. Exp. Metastasis, 13 (1995) 277-286
27. P.J. Mitchell, J. Welton, J. Staffurth, J. Court, M.D. Mason, Z. Tabi, and A. Clayton, Can urinary exosomes act as treatment response markers in prostate cancer?, J. Transl. Med., 7(2009) 4
28. H.K. Kim, K.S. Song, Y.S. Park, Y.H. Kang, Y.J. Lee, K.R. Lee, H.K. Kim, K.W. Ryu, J.M. Bae, and S. Kim, Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer. possible role of a metastasis predictor, Eur. J. Cancer, 39 (2003) 184-191
29. M.E. Tesselaar, F.P. Romijn, D.L. Van, I, F.A. Prins, R.M. Bertina, and S. Osanto, Microparticle-Associated tissue factor activity. a link between cancer and thrombosis?, J. Thromb. Haemost., 5 (2007) 520-527
30. J. Skog, T. Wurdinger, S. van Rijn, D.H. Meijer, L. Gainche, M. Sena-Esteves, W.T. Curry, Jr., B.S. Carter, A.M. Krichevsky, and X.O. Breakefield, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nat. Cell Biol., 10 (2008)1470-1476
31. C. Del, I, C.N. Shrimpton, P. Thiagarajan, and J.A. Lopez, Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation, Blood, 106(2005) 1604-1611
32. M.E. Tesselaar and S. Osanto, Risk of venous thromboembolism in lung cancer, Curr. Opin. Pulm. Med., 13 (2007) 362-367
33. J.I. Zwicker, B.C. Furie, and B. Furie, Cancer-Associated thrombosis, Crit Rev. Oncol. Hematol., 62 (2007) 126-136
34. J.I. Zwicker, H.A. Liebman, D. Neuberg, R. Lacroix, K.A. Bauer, B.C. Furie, and B. Furie, Tumor-derived tissue factorbearing microparticles are associated with venous thromboembolic events in malignancy, Clin. Cancer Res., 15 (2009)6830-6840
35. N.T. Zinkin, F. Grall, K. Bhaskar, H.H. Otu, D. Spentzos, B. Kalmowitz, M. Wells, M. Guerrero, J.M. Asara, T.A. Libermann, and N.H. Afdhal, Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease, Clin. Cancer Res., 14 (2008) 470-477